/PRNewswire/ Amarna Therapeutics, a privately-held biotechnology company developing transformative gene therapies in a range of rare and prevalent diseases,.
- €5 million financing provided by existing investors C4 holding BV and Flerie Invest AB, as well as the Netherlands Enterprise Agency (RVO) - Will fund progress of hemophilia B program
/PRNewswire/ Amarna Therapeutics, a privately-held biotechnology company developing transformative gene therapies in a range of rare and prevalent diseases,.
Photonics News: Week in Brief: 10/11/21 | Business | Oct 2021 photonics.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from photonics.com Daily Mail and Mail on Sunday newspapers.
Expert imaging support on demand Nikon Europe B.V. has announced that its first European Nikon BioImaging Lab (NBIL) based in the prestigious Leiden Bio Science Park (LBSP) is now officially open. This